AAI Releases Its Strategic Advocacy Priorities for 2026
Today, AAI released its first annual Advocacy Agenda, which was developed by the AAI Committee on Public Affairs (CPA) and…
Today, AAI released its first annual Advocacy Agenda, which was developed by the AAI Committee on Public Affairs (CPA) and…
AAI applauds Congress for approving the fiscal year (FY) 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill.
The American Association of Immunologists (AAI) is pleased to announce Marcia McNutt, PhD, President of the National Academy of Sciences (NAS), and Senator Tammy Baldwin (D-WI) as the recipients of the 2025 AAI Public Service Award.
On January 5, the Acting Director of the Centers for Disease Control and Prevention (CDC), Jim O’Neill, signed a decision…
AAI joined 230 other medical, public health and patient advocacy organizations signing a letter to every Member of Congress urging them to conduct swift and robust oversight regarding the abrupt changes to the U.S. childhood vaccine schedule.
On December 10, the AAI Council visited Washington, D.C. to advocate for robust funding for the National Institutes of Health…
AAI strongly urges the Centers for Disease Control and Prevention (CDC) to reject the recommendation and reaffirm the long-standing, evidence-based guidance to administer the first dose within 24 hours of birth.
AAI has signed a joint letter urging the CDC to update the website so that it accurately reflects the current scientific consensus that there is no causal relationship between vaccines and autism.
A group of immunologists in New York state has formed NY-CURES, the New York Coalition for Unified Research and Education…
On November 12, President Donald Trump signed a bill into law officially bringing an end to the 43-day federal government…